273 related articles for article (PubMed ID: 36344181)
1. Urothelial Carcinoma: Divergent Differentiation and Morphologic Subtypes.
Gandhi J; Chen JF; Al-Ahmadie H
Surg Pathol Clin; 2022 Dec; 15(4):641-659. PubMed ID: 36344181
[TBL] [Abstract][Full Text] [Related]
2. Molecular Pathology of Urothelial Carcinoma.
Al-Ahmadie H; Netto GJ
Clin Lab Med; 2024 Jun; 44(2):181-198. PubMed ID: 38821640
[TBL] [Abstract][Full Text] [Related]
3. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R
Urol Oncol; 2019 Nov; 37(11):826-836. PubMed ID: 31585777
[TBL] [Abstract][Full Text] [Related]
4. Urinary tract cytology showing variant morphology and divergent differentiation.
Arshia A; Hassan FA; Hensley PJ; Allison DB
Cytopathology; 2024 Mar; 35(2):199-212. PubMed ID: 37919868
[TBL] [Abstract][Full Text] [Related]
5. Updates on the Genetics and Molecular Subtypes of Urothelial Carcinoma and Select Variants.
Al-Ahmadie H; Iyer G
Surg Pathol Clin; 2018 Dec; 11(4):713-723. PubMed ID: 30447837
[TBL] [Abstract][Full Text] [Related]
6. Variant Histology in Bladder Cancer-Current Understanding of Pathologic Subtypes.
Aron M
Curr Urol Rep; 2019 Nov; 20(12):80. PubMed ID: 31781939
[TBL] [Abstract][Full Text] [Related]
7. Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation.
Cheng L; Zhang S; Alexander R; Maclennan GT; Hodges KB; Harrison BT; Lopez-Beltran A; Montironi R
Am J Surg Pathol; 2011 May; 35(5):e34-46. PubMed ID: 21490442
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous invasion from sarcomatoid urothelial carcinoma: clinical and dermatopathologic features.
Bernardes Filho F; de Melo AS; Pires AR; Lupi O; das Neves DG; da Cruz MF; Kac BK
An Bras Dermatol; 2016; 91(1):73-9. PubMed ID: 26982782
[TBL] [Abstract][Full Text] [Related]
9. Bladder Tumor Subtype Commitment Occurs in Carcinoma
Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
[TBL] [Abstract][Full Text] [Related]
10. Morphologic and Molecular Characteristics of Bladder Cancer.
Solomon JP; Hansel DE
Surg Pathol Clin; 2015 Dec; 8(4):663-76. PubMed ID: 26612220
[TBL] [Abstract][Full Text] [Related]
11. Pathology focused review of morphologic subtypes and molecular variants of urothelial carcinoma with an emphasis on clinical/treatment relevance.
Mahlow J; Gupta S
Urol Oncol; 2024 Jul; 42(7):193-202. PubMed ID: 38341364
[TBL] [Abstract][Full Text] [Related]
12. Recently described and unusual variants of urothelial carcinoma of the urinary bladder.
Samaratunga H; Delahunt B
Pathology; 2012 Aug; 44(5):407-18. PubMed ID: 22777074
[TBL] [Abstract][Full Text] [Related]
13. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.
Sung MT; Wang M; MacLennan GT; Eble JN; Tan PH; Lopez-Beltran A; Montironi R; Harris JJ; Kuhar M; Cheng L
J Pathol; 2007 Mar; 211(4):420-30. PubMed ID: 17236170
[TBL] [Abstract][Full Text] [Related]
14. Yolk sac differentiation in urothelial carcinoma - A rare variant originating from aberrant differentiation of sarcomatoid components.
Krishnamurthy K; Rosen S; Ye H; Sun Y
Ann Diagn Pathol; 2022 Jun; 58():151923. PubMed ID: 35180608
[TBL] [Abstract][Full Text] [Related]
15. A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes.
Wang L; Smith BA; Balanis NG; Tsai BL; Nguyen K; Cheng MW; Obusan MB; Esedebe FN; Patel SJ; Zhang H; Clark PM; Sisk AE; Said JW; Huang J; Graeber TG; Witte ON; Chin AI; Park JW
Proc Natl Acad Sci U S A; 2020 Jan; 117(1):563-572. PubMed ID: 31871155
[TBL] [Abstract][Full Text] [Related]
16. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.
Shanks JH; Iczkowski KA
Histopathology; 2009 Jun; 54(7):885-900. PubMed ID: 19178589
[TBL] [Abstract][Full Text] [Related]
17. Invasive urothelial carcinoma with chordoid features or abundant myxoid stroma: A reappraisal of morphologic spectrum and risk stratification based on molecular classification.
Kim JM; Choi E; Sung SH; Kang H; Park S
Pathol Res Pract; 2023 Nov; 251():154839. PubMed ID: 37801908
[TBL] [Abstract][Full Text] [Related]
18. The 2004 WHO classification of bladder tumors: a summary and commentary.
Montironi R; Lopez-Beltran A
Int J Surg Pathol; 2005 Apr; 13(2):143-53. PubMed ID: 15864376
[TBL] [Abstract][Full Text] [Related]
19. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder.
Fatima N; Osunkoya AO
Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028
[TBL] [Abstract][Full Text] [Related]
20. Molecular Pathologic Subtyping of Urothelial Bladder Carcinoma in Young Patients.
Shelekhova KV; Krykow KA; Mescherjakov IA; Mitin NP
Int J Surg Pathol; 2019 Aug; 27(5):483-491. PubMed ID: 30854907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
